Investors/Media

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Learn more about our clinical pipeline here.

Corporate Presentation

Stock Information

Change

High

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Events and Presentations

November 8, 2022 at 2:35 PM PST
Suisse 31st Annual Healthcare Conference Sign up
September 12, 2022 at 5:00 PM EDT
H.C. Wainwright 24th Annual Global Investment Conference Sign up